Home > Boards > Other Markets > ETFs > Direxion Daily Real Estate Bear 3x (DRV)

40.78 ^ 36.67 (892.21%)

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
[SMART MONEY]  Member Profile
 
Followed By 3,787
Posts 142,990
Boards Moderated 30
Alias Born 08/05/09
160x600 placeholder
STOXX Europe 600 Index Ends the Month 2.64% Lower at 462.96 -- Data Talk
The STOXX Europe 600 Index is down 12.55 points or 2.64% this month to 462.96
FTSE 100 Index Ends the Month 2.46% Lower at 7059.45 -- Data Talk
DAX Ends the Month 3.75% Lower at 15100.13 -- Data Talk
CAC 40 Index Ends the Month 1.60% Lower at 6721.16 -- Data Talk
STOXX Europe 50 Index Ends the Month 2.57% Lower at 3593.42 -- Data Talk
EURO STOXX 50 Index Ends the Month 4.41% Lower at 4063.06 -- Data Talk
U.S. Crude-Oil Stockpiles Likely Decreased in DOE Data, Analysts Say
FTSE Closes Down as Omicron Variant Sparks Volatility
Cabot Properties Sells Logistics Portfolio to Blackstone for $2.8 Billion
Oersted Secures 12-Year Power Purchase Contract With Google
Array Technologies Shares Fall With Plans for Convertible Notes Offering
U.S. Ethanol Production and Stocks Estimates for Nov. 26
TG Therapeutics Shares Drop 38% After Plans for Advisory Meeting
Consumer Confidence Fell in November Amid Inflation Worries
Clarus Therapeutics Shares Rise 27% on New U.S. Patents
Unemployment Rate Seen Ticking Down Again -- Data Week Ahead
MEI Pharma Shares Rise 22% After Positive Data for Zandelisib Trial
TG Therapeutics Shares Drop 35% Premarket After FDA Plans for Advisory Meeting
Top Company News of the Day
Codiak BioSciences Gets FDA Approval for ExoASO-STAT6 IND Application
MTN Group to Cut Stake in MTN Nigeria Via Share Placing
AbbVie Submits Europe Application for Risankizumab for Crohn's Disease
Hepion Pharmaceuticals Gets Fast-Track Designation for NASH Treatment
NextEra to Sell 50% Stake in Renewables Portfolio to Ontario Teachers' Pension Plan
Right Time for New Leadership, Inditex Chairman Says, as Founder's Daughter Prepares to Take His Place -- Update
Stellantis, Daimler's Mercedes-Benz Invest in Battery Maker Factorial Energy
FTSE Drops, John Menzies Seen Poised to Recover Strongly From Pandemic
DiscoverIE Group 1st Half Sales Hampered by Sterling -- Currency Comment
AstraZeneca: Lynparza Gets FDA Priority Review -- Update
Greece to Impose Monthly Fine on Over-60s Who Refuse Covid-19 Injection
[SMART MONEY]   Monday, 10/25/21 08:23:39 PM
Re: smitter post# 737
Post # of 740 
40.78 ^ 36.67 (892.21%)

whats up with this on only 44k volume?

same with TECS but 1M+ way more volume

Always consult an Investment Professional, my posts are my own
opinions, and not for investing decisions

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences